Cure My Disease

Don't miss your cure!

 Log in / Sign up

One prick, three diseases: new rapid test under study

NCT ID NCT06082336

Recruiting now Diagnosis Sponsor: MagIA Diagnostics Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new medical device called MagIA IBC that uses a single drop of blood from a finger prick to screen for HIV, hepatitis B, and hepatitis C at the same time. Researchers will enroll 252 adults who are known or suspected to have one of these infections. The goal is to see how accurate the test is compared to standard lab tests, and whether it works reliably with different types of blood samples.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MagIA IBC diagnostic test
What this could lead to
If successful, this could provide a quick, single finger-prick test to screen for HIV, hepatitis B, and hepatitis C, making diagnosis faster and more accessible.
What could go wrong
This is an early-stage study with only 252 participants, so results may not apply to everyone. The test's accuracy is still being evaluated, and it may not perform as well in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMBINED POINT OF CARE DIAGNOSTIC OF HIV, HBV AND HCV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatitis B virus infection hepatitis C virus infection HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COMBINED POINT OF CARE DIAGNOSTIC OF HIV, HBV AND HCV

Contacts and locations

Locations

  • Centre Hospitalier de Perpignan - Equipe Mobile Hépatites

    RECRUITING

    Perpignan, 66000, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hopital Européen de Marseille

    COMPLETED

    Marseille, France, 13003, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.